Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.

@article{Kowey2009VernakalantHF,
  title={Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.},
  author={Peter Russell Kowey and P. Dorian and L. Brent Mitchell and Craig M. Pratt and Denis Roy and Peter J. Schwartz and Jerzy Sadowski and Dorota Sobczyk and Andrzej A. Bochenek and Egon Toft},
  journal={Circulation. Arrhythmia and electrophysiology},
  year={2009},
  volume={2 6},
  pages={652-9}
}
BACKGROUND Postoperative atrial arrhythmias are common and are associated with considerable morbidity. This study was designed to evaluate the efficacy and safety of vernakalant for the conversion of atrial fibrillation (AF) or atrial flutter (AFL) after cardiac surgery. METHODS AND RESULTS This was a prospective, randomized, double-blind, placebo-controlled trial of vernakalant for the conversion of AF or AFL after coronary artery bypass graft, valvular surgery, or both. Patients were… CONTINUE READING
69 Citations
22 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 69 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Efficacy and tolerance of RSD 1235 in the treatment of atrial fibrillation or atrial flutter : results of a phase III , randomized , placebo - controlled , multicenter trial [ Abstract 10 A ]

  • DB Bharucha, PR Kowey
  • J Am Coll Cardiol
  • 2006

Similar Papers

Loading similar papers…